Lobbying Information
Subject Matters
- Economic Development
- Education
- Government Procurement
- Health
- Industry
- Research and Development
- Science and Technology
- Taxation and Finance
Subject Matter Details
Legislative Proposal, Bill or Resolution
- Federal budget with respect to public sector investments in long-term care and residential care
- Federal budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and devices
Policies or Program
- Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry
- Federal healthcare strategy with respect to COVID-19
- Federal healthcare strategy with respect to diabetes, cancer testing and long-term care
- Federal healthcare strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and laboratory diagnostic testing
- Federal science & technology strategy with respect to medical technology, specifically focusing on accelerating innovation to improve health and economic outcomes
- Federal science & technology strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry
Policies or Program, Regulation
- Discuss policies around anti-microbial resistance, infection prevention and medication errors
- North American Free Trade Agreement (NAFTA) , with respect to provisions relating to medical devices and technologies
Regulation
- Regulations under the Food and Drugs Act, including the Medical Devices Regulation, with respect to the approval of medical technologies
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Canadian Institutes of Health Research (CIHR)
-
Health Canada (HC)
-
Public Health Agency of Canada (PHAC)
-
Public Services and Procurement Canada (PSPC)
In-house Corporation Details
Description of activities
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes
Responsible officer name and position during the period of this registration
Ivy Parks,
President
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
2100 Derry Road West
Mississauga, ON L5N 0B3
Canada
Telephone number:
905-288-6000
Parent Company Information
- Becton, Dickinson and Company
-
1 Becton Drive
Franklin Lakes, NJ 07417
United States of America
Subsidiary Beneficiary Information
Becton Dickinson Canada Inc does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Ivy Parks,
President |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- Jessica McDougall,
Public Affairs Analyst |
No public offices held
- Chelsea Smallwood,
Director, Market Access & Payment Policy, MDS |
No public offices held
